Skip to main content
Log in

Thyroid protection before 123I-ioflupane (DaTSCAN) imaging

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Darcourt J, Booij J, Tatsch K, Varrone A, Vander Borght T, Kapucu ÖL, et al. EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging 2010;37:443–450. doi:10.1007/s00259-009-1267-x

    Article  PubMed  CAS  Google Scholar 

  2. AHFS Drug Information. Potassium perchlorate. Bethesda: American Society of Health-System Pharmacists; 2000. p. 3439.

  3. Martindale: the complete drug reference. 32nd ed. London: Pharmaceutical Press; 1999.

  4. Dahan A, Duhamel C, Bonnet H, Sarrut B (2001) Perchlorate de potassium et pathologies thyroïdiennes. Dossier du CNHIM, XXII

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yvan Mouraeff.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mouraeff, Y., Farid, K., Poullias, X. et al. Thyroid protection before 123I-ioflupane (DaTSCAN) imaging. Eur J Nucl Med Mol Imaging 38, 786–787 (2011). https://doi.org/10.1007/s00259-010-1726-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-010-1726-4

Keywords

Navigation